Stanford University
Showing 1-4 of 4 Results
-
Marwa Abu El Haija
Clinical Associate Professor, Pediatrics - Gastroenterology
BioI am a pediatric gastroenterologist with clinical and research interest in childhood obesity. I believe that each patient is unique in their disease and background, that is why they deserve to be approached in an individualized way. I aspire to discover what's unknown about the pathophysiologic causes of obesity, and the mechanisms of which treatments work. My clinical and research interests in pediatric obesity found home within Stanford's distinctive position academically, medically and geographically.
-
Leina Alrabadi
Clinical Associate Professor, Pediatrics - Gastroenterology
BioI enjoy working with a multidisciplinary team to care for patients who have complex medical needs with the aim of giving children a better future. As a clinical researcher, my main focus is on finding improved therapies for autoimmune and cholestatic liver diseases, since an ideal therapy currently does not exist.
-
Dahham Alsoud, MD, MSc, PhD(c)
Affiliate, Pediatrics - Gastroenterology
Visiting Postdoctoral Scholar, Pediatrics - GastroenterologyBioDr. Alsoud is a physician-scientist conducting postdoctoral research at the Rosen Lab, supported by fellowships from the Belgian American Educational Foundation and the Stanford Medicine Children’s Health Center for IBD and Celiac Disease. His research combines advanced statistical modeling and bioinformatics, leveraging multi-omics and longitudinal clinical data from the CAPTURE IBD cohort to uncover the molecular and clinical determinants of therapeutic outcomes. Through this work, he aims to reduce reliance on trial-and-error treatment strategies, strengthen evidence-based clinical decision-making, and ultimately improve outcomes and quality of life for individuals living with inflammatory bowel disease.
After earning his MD from Damascus University, Dr. Alsoud conducted his PhD research at KU Leuven, where he integrated clinical prediction, serum proteomics, and whole-blood transcriptomics to investigate treatment heterogeneity, therapeutic resistance, and response to advanced therapies in IBD. He also holds a Master of Science in Health Care Management and Policy from KU Leuven, reflecting his broader interest in designing efficient, patient- and provider-centered models of healthcare delivery. Dr. Alsoud serves as an Editorial Fellow for Basic and Translational Science at Inflammatory Bowel Diseases and has contributed to the peer review of more than 150 manuscripts in the field.
